Haematopoietic stem cell transplantation for patients with chronic myeloid leukaemia after failure of tyrosine kinase inhibitor therapy

被引：0
作者：
Prayongratana, K.
Forrest, D.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S428 / S429
页数：2
相关论文
共 50 条
  • [41] TYROSINE KINASE INHIBITOR ASSOCIATED DILATED CARDIOMYOPATHY IN CHRONIC MYELOID LEUKAEMIA
    Amilineni, N.
    Bhogal, S.
    Sankhyan, P.
    Cook, C.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (02) : 433 - 433
  • [42] Chronic myeloid leukaemia and tyrosine kinase inhibitor therapy: assessment and management of cardiovascular risk factors
    Ross, David M.
    Arthur, Chris
    Burbury, Kate
    Ko, Brian S.
    Mills, Anthony K.
    Shortt, Jake
    Kostner, Karam
    INTERNAL MEDICINE JOURNAL, 2018, 48 : 5 - 13
  • [43] Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Tyrosine Kinase Inhibitor Therapy Cessation
    Kota, Vamsi
    Atallah, Ehab
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (08) : 480 - 487
  • [44] Results of stem cell transplantation in paediatric patients with chronic myeloid leukaemia
    Suttorp, M
    Claviez, A
    Martiniak, Y
    BONE MARROW TRANSPLANTATION, 2005, 35 : S20 - S20
  • [45] Imatinib therapy for chronic myeloid leukaemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis
    Martinelli, G
    Palandri, F
    Amabile, M
    Bonifazi, F
    Bandini, G
    Benedetti, F
    Usala, E
    Angelucci, E
    Tiribelli, M
    Fanin, R
    Sorio, M
    Arpinati, M
    Testoni, N
    Falcioni, S
    Giannini, M
    Poerio, A
    Soverini, S
    Pane, F
    Rosti, G
    Baccarani, M
    BONE MARROW TRANSPLANTATION, 2005, 35 : S236 - S236
  • [46] Myeloablative allogeneic haematopoietic stem cell transplantation for 25 patients under 18 years of age with chronic myeloid leukaemia
    Nacer, R. Ahmed
    Benakli, M.
    Baazizi, M.
    Belhadj, R.
    Rahmoune, N.
    Mehdid, F.
    Harieche, F.
    Ouali, D. Ait
    Zerhouni, F.
    Hamladji, R. M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S383 - S384
  • [47] Effect of prior therapy with Nilotinib or Dasatinib on the outcome after allogeneic stem cell transplantation for patients with chronic myeloid leukaemia
    Schleuning, M.
    Olavarria, E.
    Scholten, M.
    van Biezen, A.
    Michallet, M.
    Nagler, A.
    Hochhaus, A.
    Grigg, A.
    Silver, R.
    Schuld, P.
    Niederwieser, D.
    de Witte, T.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S32 - S32
  • [48] Autologous haematopoietic stem cell transplantation as an intensive consolidation therapy for adult patients in remisssion from acute myeloid leukaemia
    Genadieva-Stavrik, S.
    Pivkova, A.
    Stojanoski, Z.
    Krstevaka-Balkanov, S.
    Milenkov, V.
    Georgievski, B.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S417 - S417
  • [49] Effect of prior therapy with nilotinib or dasatinib on the outcome after allogeneic stem cell transplantation for patients with chronic myeloid leukaemia
    Schleuning, M.
    Scholten, M.
    van Biezen, A.
    Nagler, A.
    Apperley, J.
    Michallet, M.
    Grigg, A.
    Silver, R.
    Niederwieser, D.
    De Witte, T.
    Olavarria, E.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S240 - S240
  • [50] Follow-up of chimerism in myeloid cell fraction after allogeneic haematopoietic stem cell transplantation (HSCT) for patients with acute myeloid leukaemia
    Mollet, I.
    Revez, D.
    Martin, C.
    Plesa, C.
    Giannoli, C.
    Nicolini, F.
    Canas, G.
    Nicolas, E.
    Thomas, X.
    Dubois, V.
    Michallet, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S106 - S107
12345